Addition of Baylor and University of Texas to trials absolutely will help enrollment. Small company with limited resources absolutely suffered when NY/NJ brought, for the meantime, Covid under control.

Momentum takes forever to build, but I cannot believe that ICU physicians in Texas are not aware of leronlimab.